Pennington, New Jersey
United States
28
2024-08-22
The entities that hold a legal rights for patent applications filed by inventor MORIN Paul E.:
Paul E. MORIN from Pennington, US has applied for patents for these inventions. The list has both pending applications and granted patents:
RADIOLABELED FIBRONECTIN BASED SCAFFOLDS AND ANTIBODIES AND THERANOSTIC USES THEREOF
#2 | 2023-09-21PRODRUGGABLE ANTIBODIES, PRODRUGS THEREOF, AND METHODS OF USE AND MAKING
#3 | 2023-03-23IL-10 AND USES THEREOF
#4 | 2022-11-03PET IMAGING WITH PD-L1 BINDING POLYPEPTIDES
#5 | 2022-10-20Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptides
#6 | 2022-08-11ANTI-CTLA4 ANTIBODY PRODRUGGABLE (PROBODY) AT A CDR POSITION
#7 | 2022-07-07Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptides
#8 | 2022-06-16Nucleic acids encoding modified FGF-21 polypeptides, vectors and cells containing, and use thereof
#9 | 2022-01-06PD-L1 binding polypeptides for imaging
#10 | 2021-07-01Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof
#11 | 2021-03-04Methods and compositions for deuterated biologics
#12 | 2019-12-19Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides
#13 | 2019-11-14PD-L1 binding polypeptides for imaging
#14 | 2019-08-22Method of treating cardiovascular disease and heart failure with modified relaxin polypeptides
#15 | 2019-07-04Serum albumin binding molecules
#16 | 2019-06-20PET imaging with PD-L1 binding polypeptides
#17 | 2019-04-04METHODS AND COMPOSITIONS FOR DEUTERATED BIOLOGICS
#18 | 2019-02-21Prodruggable antibodies, prodrugs thereof, and methods of use and making
#19 | 2018-08-30Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides and uses thereof
#20 | 2018-08-09Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
#21 | 2017-09-14PD-L1 binding polypeptides for imaging
#22 | 2017-07-06Therapeutic uses of modified FGF-21 polypeptides
#23 | 2017-05-25Serum albumin binding molecules
#24 | 2017-02-02Modified FGF-21 polypeptides comprising an internal deletion and uses thereof
#25 | 2016-04-28Modified FGF-21 polypeptides comprising an internal deletion and uses thereof
#26 | 2015-06-04Serum albumin binding molecules
#27 | 2011-12-15Serum albumin binding molecules
#28 | 2007-06-28Beta secretase exosite binding peptides and methods for identifying beta secretase modulators
1180571 ⎘